These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Progressive familial intrahepatic cholestasis. Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. Orphanet J Rare Dis; 2009 Jan 08; 4():1. PubMed ID: 19133130 [Abstract] [Full Text] [Related]
3. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history. Davit-Spraul A, Fabre M, Branchereau S, Baussan C, Gonzales E, Stieger B, Bernard O, Jacquemin E. Hepatology; 2010 May 08; 51(5):1645-55. PubMed ID: 20232290 [Abstract] [Full Text] [Related]
5. DHPLC screening for mutations in progressive familial intrahepatic cholestasis patients. Shapiro R, Anikster Y, Yardeni T, Korem S, Hartman K, Shamir R, Broide E, Levine A, Bujanover Y, Bercovich D. J Hum Genet; 2010 May 08; 55(5):308-13. PubMed ID: 20414253 [Abstract] [Full Text] [Related]
6. Genetics and Molecular Modeling of New Mutations of Familial Intrahepatic Cholestasis in a Single Italian Center. Giovannoni I, Callea F, Bellacchio E, Torre G, De Ville De Goyet J, Francalanci P. PLoS One; 2015 May 08; 10(12):e0145021. PubMed ID: 26678486 [Abstract] [Full Text] [Related]
8. Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy. van der Woerd WL, van Mil SW, Stapelbroek JM, Klomp LW, van de Graaf SF, Houwen RH. Best Pract Res Clin Gastroenterol; 2010 Oct 08; 24(5):541-53. PubMed ID: 20955958 [Abstract] [Full Text] [Related]
9. Heterozygous mutations of ATP8B1, ABCB11 and ABCB4 cause mild forms of Progressive Familial Intrahepatic Cholestasis in a pediatric cohort. Mínguez Rodríguez B, Molera Busoms C, Martorell Sampol L, García Romero R, Colomé Rivero G, Martín de Carpi J. Gastroenterol Hepatol; 2022 Oct 08; 45(8):585-592. PubMed ID: 34942279 [Abstract] [Full Text] [Related]
10. [Liver disease associated with hereditary defects of hepatobiliary transporters]. Wendum D. Ann Pathol; 2010 Dec 08; 30(6):426-31. PubMed ID: 21167428 [Abstract] [Full Text] [Related]
11. Progressive familial intrahepatic cholestasis. Genetic basis and treatment. Jacquemin E. Clin Liver Dis; 2000 Nov 08; 4(4):753-63. PubMed ID: 11232355 [Abstract] [Full Text] [Related]
12. Current and future therapies for inherited cholestatic liver diseases. van der Woerd WL, Houwen RH, van de Graaf SF. World J Gastroenterol; 2017 Feb 07; 23(5):763-775. PubMed ID: 28223721 [Abstract] [Full Text] [Related]
13. Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings. Morotti RA, Suchy FJ, Magid MS. Semin Liver Dis; 2011 Feb 07; 31(1):3-10. PubMed ID: 21344347 [Abstract] [Full Text] [Related]
14. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis. Kubitz R, Dröge C, Kluge S, Stross C, Walter N, Keitel V, Häussinger D, Stindt J. Clin Rev Allergy Immunol; 2015 Jun 07; 48(2-3):273-84. PubMed ID: 25342496 [Abstract] [Full Text] [Related]
15. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases. Chen HL, Wu SH, Hsu SH, Liou BY, Chen HL, Chang MH. J Biomed Sci; 2018 Oct 26; 25(1):75. PubMed ID: 30367658 [Abstract] [Full Text] [Related]
16. Hepatic immunohistochemistry of bile transporters in progressive familial intrahepatic cholestasis. El-Guindi MA, Sira MM, Hussein MH, Ehsan NA, Elsheikh NM. Ann Hepatol; 2016 Oct 26; 15(2):222-9. PubMed ID: 26845599 [Abstract] [Full Text] [Related]
17. Differences in presentation and progression between severe FIC1 and BSEP deficiencies. Pawlikowska L, Strautnieks S, Jankowska I, Czubkowski P, Emerick K, Antoniou A, Wanty C, Fischler B, Jacquemin E, Wali S, Blanchard S, Nielsen IM, Bourke B, McQuaid S, Lacaille F, Byrne JA, van Eerde AM, Kolho KL, Klomp L, Houwen R, Bacchetti P, Lobritto S, Hupertz V, McClean P, Mieli-Vergani G, Shneider B, Nemeth A, Sokal E, Freimer NB, Knisely AS, Rosenthal P, Whitington PF, Pawlowska J, Thompson RJ, Bull LN. J Hepatol; 2010 Jul 26; 53(1):170-8. PubMed ID: 20447715 [Abstract] [Full Text] [Related]
18. Liver disease associated with canalicular transport defects: current and future therapies. Stapelbroek JM, van Erpecum KJ, Klomp LW, Houwen RH. J Hepatol; 2010 Feb 26; 52(2):258-71. PubMed ID: 20034695 [Abstract] [Full Text] [Related]
19. A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report. Qiao F, Ren F, Lu W, Yang H, Mo G, Wang S, Liu L, Xu X. BMC Med Genomics; 2023 Jul 25; 16(1):171. PubMed ID: 37488596 [Abstract] [Full Text] [Related]
20. Genetic cholestasis, causes and consequences for hepatobiliary transport. Jansen PL, Sturm E. Liver Int; 2003 Oct 25; 23(5):315-22. PubMed ID: 14708891 [Abstract] [Full Text] [Related] Page: [Next] [New Search]